Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$391K Buy
+9,427
New +$358K 0.02% 603
2017
Q1
Sell
-14,695
Closed -$453K 957
2016
Q4
$453K Buy
+14,695
New +$454K 0.04% 392
2016
Q2
Sell
-29,257
Closed -$785K 855
2016
Q1
$785K Buy
+29,257
New +$716K 0.05% 340
2015
Q4
Sell
-16,984
Closed -$473K 1024
2015
Q3
$473K Buy
+16,984
New +$614K 0.03% 481
2015
Q2
Sell
-34,269
Closed -$1.04M 1051
2015
Q1
$1.04M Buy
+34,269
New +$889K 0.06% 313
2014
Q4
Sell
-10,413
Closed -$207K 879
2014
Q3
$207K Buy
+10,413
New +$219K 0.01% 672

Other funds holding RGEN

Airain Ltd's RGEN Position: Q2 2017 in Review

Airain Ltd opened a new position in Repligen (RGEN) in Q2 2017: 9,427 shares worth $391K. The stake represents 0.02% of the portfolio and ranks #603 among its holdings. This is a return to the name: Airain Ltd previously reported a position in RGEN as recently as Q4 2016.

Airain Ltd first reported a position in RGEN in Q3 2014 and has held it in 6 quarters since. The position peaked at $1.04M in Q1 2015. 199 funds tracked by Wall St. Rank hold RGEN as of Q2 2017.

  • Airain Ltd held 9,427 shares of Repligen worth $391K as of Q2 2017.
  • Repligen was a new Airain Ltd position in Q2 2017.
  • Repligen made up 0.02% of Airain Ltd's portfolio in Q2 2017, its #603 holding.
  • Airain Ltd first reported a position in Repligen in Q3 2014 and has held it in 6 quarters since.
  • Airain Ltd's Repligen position peaked at $1.04M in Q1 2015.
  • 199 funds tracked by Wall St. Rank held Repligen as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.